References
|
Lobos-Gonzales L, et al. Caveolin-1 is a risk factor for postsurgery metastasis in preclinical melanoma models. Melanoma Res 24(2):108-119, 2014. PubMed: 24500501
Tian, F et al. miR-33a Is Downregulated in Melanoma Cells and Modulates Cell Proliferation by Targeting Pctaire1. Oncol Lett 4(11):2741-46, 2016. PubMed: 27073545
Gutteridge RE, et al. Targeted Knockdown of Polo-Like Kinase 1 Alters Metabolic Regulation in Melanoma. Cancer Lett 394:13-21, 2017. PubMed: 28235541
Oehler B, et al. TRPA1 is functionally expressed in melanoma cells but is not critical for impaired proliferation caused by allyl isothiocyanate or cinnamaldehyde. Naunyn-Schmiedebergs Arch Pharmacol 385(6):555-563, 2012. PubMed: 22426997
Yang B, et al. Hyperoside Protects Human Primary Melanocytes against H2O2-Induced Oxidative Damage. Mol Med Rep 6(13):4613-9, 2016. PubMed: 27082158
Mazar J, et al. The Regulation of miRNA-211 Expression and Its Role in Melanoma Cell Invasiveness. PLoS One 11(5):e13779, 2010. PubMed: 21072171
Feng JH, et al. A Novel Plant Sesquiterpene Lactone Derivative, DETD-35, Suppresses BRAFV600E Mutant Melanoma Growth and Overcomes Acquired Vemurafenib Resistance in Mice. Mol Cancer Ther 6(15):1163-76, 2016. PubMed: 27048951
Dodey TS, et al. A tool kit for rapid cloning and expression of recombinant antibodies. Sci Rep 4:5885, 2014. PubMed: 25073855
Yang B, et al. Hyperoside elevates the melanin content and promotes the migration of human melanocytes. Int J Clin Exp Med 10(2):2953-2959, 2017. ISSN: 1940-5901/IJCEM0033391
|